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Abstract
Carcinomas, such as colon cancer, initiate their invasion by rescuing the innate plasticity of both epithelial cells and
stromal cells. Although Snail is a transcriptional factor involved in the Epithelial-Mesenchymal Transition, in recent
years, many studies have also identified the major role of Snail in the activation of Cancer-Associated Fibroblast (CAF)
cells and the remodeling of the extracellular matrix. In CAFs, Platelet-derived growth factor (PDGF) receptor signaling is
a major functional determinant. High expression of both SNAI1 and PDGF receptors is associated with poor prognosis
in cancer patients, but the mechanism(s) that underlie these connections are not understood. In this study, we
demonstrate that PDGF-activated fibroblasts stimulate extracellular matrix (ECM) fiber remodeling and deposition.
Furthermore, we describe how SNAI1, through the FAK pathway, is a necessary factor for ECM fiber organization. The
parallel-oriented fibers are used by endothelial cells as “tracks”, facilitating their activation and the creation of tubular
structures mimicking in vivo capillary formation. Accordingly, Snail1 expression in fibroblasts was required for the co-
adjuvant effect of these cells on matrix remodeling and neoangiogenesis when co-xenografted in nude mice. Finally,
in tumor samples from colorectal cancer patients a direct association between stromal SNAI1 expression and the
endothelial marker CD34 was observed. In summary, our results advance the understanding of PDGF/SNAI1-activated
CAFs in matrix remodeling and angiogenesis stimulation.
Introduction
Emerging evidences indicate that human carcinomas
often have significant stromal reactions, characterized by
the existence of stromal cells and extracellular matrix
proteins1. In solid tumors, including primary and meta-
static colorectal cancer (CRC), fibroblasts are the main
component of tumor stroma, receiving various names,
such as Cancer-Associated Fibroblasts (CAFs)1. CAF
populations are heterogeneous2,3 and directly promote
tumor growth and progression throughout the induction
of stem cell properties, tumor cell motility and implan-
tation, but also enhance angiogenesis, inflammation and
ECM remodeling4.
CAFs are characterized by the upregulation of proteins,
such as α-SMA, fibroblast specific protein 1 (FSP1),
fibroblast activation protein (FAP) and platelet-derived
growth factor receptors (PDGFR)-α/β5,6. High stromal
expression or activation of PDGFR-β is associated with
poor prognosis in breast, prostate and gastrointestinal
tumors7–10. The involvement of PDGF isoforms in both
autocrine and paracrine stimulation of tumor growth has
been extensively studied11,12. PDGF-BB expression, by
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Fig. 1 (See legend on next page.)
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tumor epithelial cells or by endothelial cells (ECs),
enhances angiogenesis, by recruiting pericytes to neo-
vessels, and promotes an activated phenotype on fibro-
blasts13–16.
Snail1, a zinc finger transcriptional factor, is key in the
initiation of epithelial-mesenchymal transition (EMT)17.
Although adult fibroblasts normally do not express
Snail118, there are some situations in which Snail1 protein
is detected in these cells, such as wound healing or cancer
progression18–21.
As mentioned above, PDGF-BB induces an activated
state in fibroblasts13,22, but the molecular pathways are
poorly defined. We proposed Snail1 as a marker of acti-
vated fibroblasts21. Snail1-expressing fibroblasts promote
ECM deposition accompanied by ECM degradation, and
increase the stiffness and orientation of ECM fibers19,23–
25. In addition, ECM is a major regulator of vasculogenesis
and angiogenesis: it is a physical scaffold that controls
endothelial cell activity through chemical and mechanical
signals26. Here, we demonstrate that PDGF-BB stimulates
Snail1 expression in fibroblasts, in a FAK pathway-
dependent manner, resulting in matrix remodeling. 3D-
derived matrices from Snail1-expressing fibroblasts
induce tubulogenesis in endothelial cells. In animal
models, xenografted tumors composed by colon tumor
cells and Snail1 KO fibroblasts showed reduced ability for
neoangiogenesis with respect to Snail1 wild-type fibro-
blasts. Moreover, we observed a direct association
between Snail1 stromal expression and angiogenesis in
human colon cancer patients. These findings reveal a new
role for Snail1-expressing fibroblasts and the PDGF
pathway in tumor angiogenesis.
Results
PDGF stimulates growth and extracellular matrix
production of fibroblasts
To study the possible influence of PDGF ligand on ECM
characteristics, BJ-hTERT fibroblasts were incubated with
or without exogenous PDGF; the cells were supplemented
with ascorbic acid to enhance matrix production. After
PDGF treatment, fibroblasts displayed a more aligned
phenotype (Fig. 1a).
3-D matrices derived from PDGF-stimulated fibroblasts
were decellularized and stained for Collagen I and
Fibronectin to study matrix composition and structural
changes. Collagen I and Fibronectin protein expression
increased in matrices derived from PDGF-stimulated
fibroblasts (Fig. 1b). Consequently, matrix thickness was
increased by PDGF-BB stimulation, as measured by
Confocal Microscopy (Fig. 1c). Moreover, Fibronectin and
Collagen I fibers revealed a parallel pattern, determined by
Directionality Histograms, in PDGF-stimulated fibro-
blasts, as shown in Fig. 1d. We previously described the
involvement of the p65 subunit of NF-κB in activating
fibronectin transcription25. Currently, our results showed
an increase of p65 phosphorylation in BJ-hTERT fibro-
blasts after PDGFBB stimulation (Sup. Fig. 1). The
observed high degree of organization of ECM fibers
induced by PDGF is not due to the number of BJ-hTERT
fibroblasts, since this number was not different at the end
of the experiment (Sup. Fig. 2).
A previous study of our group determined the gene
expression profile of control and PDGF-stimulated
BJhTERT fibroblasts (GEO Series accession number:
GSE40720). We re-analyzed these data focusing on the
protein related with the composition, organization and
remodeling of the ECM. Gene Set Enrichment Analysis
(GSEA) was done using the Molecular Signatures Data-
base (MSigDB) which is a collection of annotated gene
sets for use with GSEA software. (http://software.
broadinstitute.org/gsea/msigdb/collections.jsp). Our ana-
lysis computed overlaps between our gene set and gene
sets in MSigDB (we included gene sets derived from the
KEGG and Reactome pathway databases and the hallmark
gene set database). The analysis shows important gene
sets involved, with FDR q-value below 0.05. Interestingly,
the Extracellular Matrix Organization and the Collagen
Formation is observed as one of the main biological
processes involved. Similarly, angiogenesis regulation is
also observed as a candidate hallmark to be affected by the
deregulated genes (Sup. Table 1).
(see figure on previous page)
Fig. 1 PDGF-stimulated fibroblasts enhance thicker and anisotropic extracellular matrix, which promotes endothelial cell activation. a
Binary images representative of the cellular orientation of the BJ-hTERT fibroblasts treated or not with PDGF-BB (above) and directionality histograms
(below) calculated with the Image J software which represent the frequency of distribution of cell angles (centered on the 0 ° angle). b Increase in
protein expression of extracellular proteins such as fibronectin and Collagen I in PDGF-stimulated fibroblasts derived from ECM. c Increase of ECM
thickness, determined by confocal microscopy, in those ECMs derived from PDGF-stimulated fibroblasts. d Increase in protein and organization of
extracellular proteins such as fibronectin and Collagen I in PDGF-stimulated fibroblasts derived from ECM. Under the image its represented the
directionality histograms calculated with the Image J software which represent the frequency of distribution of protein fibers angles (centered on the
0 ° angle). e, f Endothelial cell activation was observed by formation of capillary-like structures on matrices derived from PDGF-stimulated fibroblasts
(e) and increased expression of angiogenesis-related markers (f). g Increase expression of β1 and β3 integrins subunits in HUVECs from PDGF-derived
matrices. *p value < 0,05; ***p value < 0,001. All results are derived from 2–4 independent experiments, each performed in duplicate
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Fig. 2 Fibroblast alignment, matrix remodeling and endothelial cell activation are dependent on Collagen I organization and FAK. a, b
Collagen I organization (a) and deposition (b) were blocked by increased concentrations of LOX or FAK inhibitors. Directionality histograms,
calculated with the Image J software, represent the frequency of distribution of protein fibers angles (centered on the 0 ° angle). c Full inhibition of
endothelial tubulogenesis in matrices derived from LOX or FAK inhibitor-treated fibroblasts. *p value < 0,05; **p value < 0,01; ***p value < 0,001. All
results are derived from 2–4 independent experiments, each performed in duplicate
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Derived Matrices from PDGF-stimulated fibroblasts
enhance the activation and tubulogenesis of HUVECs
To study the role of the extracellular matrix on the
endothelial cell functions, human endothelial HUVEC
cells were seeded over decellularized matrices derived
from PDGF-stimulated or non-stimulated BJ-hTERT
fibroblasts. As shown in Sup, Fig. 3, HUVEC cells do not
express PDGF-β receptor and do not tyrosine phosphor-
ylate Akt following addition of exogenous PDGF. Inter-
estingly, HUVECs seeded on matrices from PDGF-
stimulated fibroblasts showed more defined networks of
capillary-like structures and anastomosing cords in cells
(commonly known as tube formations), than in HUVECs
seeded on matrices from non-stimulated fibroblasts
(Fig. 1e).
Angiogenesis-related markers (Fig. 1f), including phos-
pho-ERK1/2 and MMP-9, increased in HUVECs from
PDGF-derived matrices. MT1-MMP also increased
slightly in these matrices, while VCAM-1 decreased and
no changes in VE-Cadherin were detected. In addition, an
increase expression of β1 and β3 integrins subunits,
related with the attachment of the endothelial cells to the
ECM for neoangiogenesis, was observed in HUVECs from
PDGF-derived matrices (Fig. 1g).
Taken together, these data demonstrate that 3D-ECMs
derived from PDGF-stimulated fibroblasts stimulate
HUVEC activation and attachment to ECM.
Endothelial cell activation is blocked by the inhibition of
Collagen I fiber organization in fibroblasts-derived
matrices
To investigate whether fiber alignment was responsible
for the tubulogenesis process on 3D-derived matrices, we
proceed to inhibit Collagen fiber organization using a
pharmacological approach. Fist we used a competitive
inhibitor (beta-aminopropionitrile, BAPN) of the activity
of the Collagen-crosslinker enzyme, lysyl oxidase
(LOX)27. In line with previous data19, the effects of PDGF-
BB on Collagen I organization and deposition were
blocked by BAPN (Fig. 2a, b, respectively) although this
compound did not affect fibroblast growth or organiza-
tion (Sup. Fig. 4a). Neither Fibronectin fiber disposition
nor the amount were affected by BAPN (Sup. Fig. 4B and
4C). Predictably, no changes in LOX protein were
observed, since BAPN functions as an inhibitor of LOX
activity (Sup. Fig. 4D).
Interestingly, the PDGF-dependent up-regulation of
tubulogenesis was reverted when endothelial cells were
seeded on BAPN-treated 3D matrices, demonstrating the
pivotal role of fiber organization in this process (Fig. 2c).
Since PDGF signals through Erk, PI3K/Akt and FAK
pathways, we also used inhibitors for these pathways to
assess a possible role of these proteins in the regulation of
the ECM changes. All these compounds specifically
inhibited the PDGF-stimulated phosphorylation of its
target (Sup. Fig. 5).
Collagen I deposition was completely reverted by the
Akt inhibitor (LY294002) (Fig. 2b) whereas the FAK
inhibitor (PF573228) showed a more prominent effect on
both fibroblast organization and matrix fiber orientation
(Sup. Fig. 6A and Fig. 2a, b). On the other hand, fibroblast
growth and matrix fiber orientation were not affected by
the ERK inhibitor (UO126), that only caused a slight
reduction in Collagen I deposition (Sup. Fig. 6A, 6B and
6C). Accordingly, HUVEC tubulogenesis was completely
inhibited in matrices derived from FAK inhibitor-treated
fibroblasts (Fig. 2c).
Taken together, these experiments identify the FAK
pathway as an important mediator of PDGF-dependent
effects in matrix deposition and alignment by fibroblasts,
consequently this pathway inhibition prevent endothelial
cell activation.
Fibroblast alignment, matrix remodeling and enhanced
tubulogenesis by PDGF are dependent on Snail1-fibroblast
expression
We recently described Snail1 as a potential marker of
activated fibroblasts with paracrine-derived pro-tumori-
genic effects on colon cancer cells21. We checked the
effect of the ERK1/2, PI3K/Akt and FAK inhibitors on
Snail1 protein expression in PDGF-stimulated fibroblasts.
Snail1 was induced at serum-free levels in PDGF-treated
fibroblasts, with maximum expression at 24 h, together
with increased α-SMA expression, the actin isoform
involved in ECM contraction and remodeling (Sup. Fig.
7A and 7B). Moreover, Snail1 nuclear translocation was
also observed in PDGF-treated fibroblasts (Sup. Fig. 7C).
α-SMA was remarkably down-regulated by Akt and FAK
inhibitors (Sup. Fig. 7d); in contrast Snail1 expression was
only sensitive to the FAK inhibitor (Sup. Fig. 7C and D).
Therefore, the induction in Snail1 expression in fibro-
blasts treated with PDGF is dependent on the FAK
pathway.
Furthermore, Snail1 has previously been described as
modifying the expression of some ECM proteins,
including fibronectin and Collagen I25,28–31. In this way, 1.
BR3G human fibroblasts with ectopic SNAI1 over-
expression were incubated with PDGF and the expression
of different ECM proteins were analyzed by the Array
Human Extracellular Matrix and Adhesion Molecules.
Interestingly, as it is shown in Sup. Table 2, a synergic
effect of SNAI1 overexpression and PDGF stimulation is
observed regarding the regulation of several ECM related
proteins, including structural proteins as different types of
Collagen, Fibronectin, Laminins; ECM adherents proteins
as Integrins subunits; Secreted proteins as Metallopro-
teinases, TGFβ, TIMP2.
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Fig. 3 (See legend on next page.)
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To deeply study the possible effects of Snail1 expression
on ECM, 3-D matrices were generated from Mouse
Embryonic Fibroblasts (MEFs) either wild-type (wt) or
KO for SNAI1 under PDGF stimulation. A greater
alignment of cells was shown in wt MEFs on PDGF sti-
mulation (Fig. 3a), as was previously observed in BJ-
hTERT cells. In contrast, alignment of fibroblast cells was
not observed when Snail1 was depleted in fibroblasts,
independently of PDGF stimulation (Fig. 3a).
Decellularized 3D-ECMs generated by KO MEFs
showed fewer Fibronectin and specifically Collagen I than
matrices produced by wt MEFs (Fig. 3b). In parallel, a
decrease of p65 phosphorilation was observed in KO
MEFs regarding wt MEFs (Sup. Fig. 8). Moreover, wt
MEFS upon PDGF stimulation produced more Collagen I,
whereas no changes in the Collagen I amount were
observed in KO MEFs. Directionality histograms showed
that wt MEFs treated with PDGF exhibited a high degree
of both Fibronectin and Collagen I fiber organization (Fig.
3c). In contrast, PDGF failed to reorganize ECM fibers in
KO MEF-derived matrices (Fig. 3c).
After fibroblast removal, HUVECs were seeded on 3-D
derived matrices to study the angiogenic switch and
tubulogenesis. Enhanced tubulogenesis was observed in
matrices derived from wt MEFs treated with PDGF, while
these capillary-like structures were not observed in those
matrices derived from non-stimulated wt. Addition of
PDGF to Snail1 KO MEFs did not increase HUVEC
tubulogenesis effects found in HUVECs seeded on Snail1
KO MEF-derived matrices, regardless of PDGF stimula-
tion (Fig. 3d).
In accordance to this data, matrices derived from PDGF-
stimulated fibroblasts significantly modify angiogenic and
ECM attachment markers of endothelial cells in a Snail1-
dependent manner. Thus, a decrease in endothelial cell
activation markers (pERK1/2, VE-Cadherin, MMP-9) and
slightly higher levels of VCAM1 were observed in HUVEC
cells seeded on Snail1 KO MEF-derived matrices (Fig. 3e).
The increase expression of β3 integrins subunits was also
observed in HUVEC cells seeded on wt MEF-derived
matrices with PDGF treatment. In contrast, a down-
regulation of β3 integrins was observed when Snail1 was
depleted in fibroblasts, and PDGF stimulation only pro-
duced a vaguely increase of them (Fig. 3f).
Taken together, these analyses demonstrated that
depletion of Snail1 from fibroblasts blocked their ability to
enhance endothelial tubulogenesis in a PDGF/FAK-
dependent manner.
Snail1 expressing fibroblasts enhances invasion and
proliferation of HUVECs
Angiogenesis requires ECM remodeling to allow the
migration and invasion of endothelial cells into sur-
rounding stroma. To investigate further the effect of
Snail-expressing fibroblasts on the invasion of endothelial
cells, we developed an organotypic co-culture system in
which control or Snail1 KO MEFs were embedded in type
I Collagen gel plus PDGF stimulation, and HUVECs were
seeded at the top of the gel.
Collagen gels including Snail1 wt MEFs showed abun-
dant invasive endothelial cells, with individual (arrows)
and collective cohort invasion (arrowheads) (Fig. 4a, b). In
contrast, when Snail1 KO MEFs were included only a few
individual invading cells or small cell groups were
observed (Fig. 4a, b).
Furthermore, PDGF addition to gels with wt MEFs
induced a higher HUVEC invasion as collective cohort
(Fig. 4a, b). No PDGF effects were observed on HUVEC
invasion seeded on matrices with Snail1 KO fibroblasts
(Fig. 4a, b).
The capability to contract Collagen gels is a typical trait
of activated fibroblast3. We evaluated collagen contraction
in gels containing WT or Snail1 KO MEFs. After 6 days
co-culture, the gel diameter was measured before the air-
liquid co-culture phase and invasion of HUVECs. Col-
lagen I gels were contracted to their maximum level,
reaching 4.40 ± 0.70 mm diameter in PDGF-treated gels
with control fibroblasts vs. 6.80 ± 1.32 mm diameter in
non-treated gels with control fibroblasts. However, no
clear changes in gel contraction were found in gels from
non-treated (10.88 ± 0.64 mm) or PDGF-treated Snail1
KO MEFs (12.60 ± 0.55) (Fig. 4c).
Another essential step in angiogenesis is the prolifera-
tion of endothelial cells. Therefore, we next studied
whether 3D-derived matrices from PDGF-stimulated
fibroblasts enhance endothelial cell proliferation in a
Snail1-dependent way. Green fluorescent-labeled
HUVECs cultured on decellularized 3D-ECMs generated
Fig. 3 Snail regulates fibroblast alignment, matrix remodeling and tubulogenesis in response to PDGF. a SNAI 1 expression is required for
alignment of fibroblasts dependent on PDGF ligand. Below the representative images the directionality histograms, calculated with the Image J
software, show the frequency of distribution of cell angles (centered on the 0 ° angle). b, c Increase in ECM fiber deposition (b) and Organization (c)
in matrices derived from PDGF-stimulated fibroblasts were dependent on SNAI1 expression. Under the image its represented the directionality
histograms calculated with the Image J software, representing the frequency of distribution of protein fibers angles (centered on the 0° angle).
d, e Formation of capillary-like structures on matrices derived from PDGF-stimulated fibroblasts (d) and increased expression of angiogenesis-related
markers (e) are blocked in SNAI1 KO fibroblasts. f Down-regulation of β3 integrins in HUVECs from SNAI1 KO fibroblasts matrices. All results are
derived from 2–4 independent experiments, each performed in duplicate
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Fig. 4 Invasion and proliferation of HUVECs are dependent on SNAI1-expressing fibroblasts. a Snail1 KO MEFs gels had fewer invading
endothelial cells as both individual invasion (arrows) and collective cohorts (arrowheads) for Snail1 wt MEFs. Moreover, PDGF treatment enhances
collective cohort invasion in HUVEC cells seeded on gels derived from Snail1 wt MEFs, but not in those derived from Snail1 ko MEFs. b Quantification
of collective cohorts of invading HUVEC cells. c Deletion of Snail1 in ko MEFs avoided Collagen I gel contraction even under PDGF treatment. d Snail1
deletion blocked the increase of endothelial cell proliferation in cells seeded on ECM derived from PDGF-stimulated fibroblasts. *p value < 0,05; **p
value < 0,01; ***p value < 0,001. All results are derived from 2–4 independent experiments, each performed in duplicate
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by PDGF-treated Snail wt MEFs showed a higher pro-
liferation rate than non-treated control MEFs or Snail1
KO MEFs, regardless of the growth factor stimulation
(Fig. 4d).
These results reveal the role of Snail1-activated fibro-
blasts in endothelial cell angiogenesis, through mechan-
isms involving activation, invasion and proliferation.
PDGF and SNAI1 also control matrix remodeling in CAFs
To verify the previous results about PDGF-fibroblast
activation and matrix remodeling, we took advantage of
our primary fibroblast isolation method as an ex vivo
approach32. We first compared ECM alignment in
normal fibroblasts (NFs) and CAFs from 3 colorectal
patients. The images revealed an increase in ECM
organization in CAFs, as seen after the analysis of Col-
lagen I and Fibronectin fibers by immunofluorescence
(Sup. Fig. 9). PDGF treatment of CAFs from 3 colorectal
patients showed that CAFs generated 3D-ECMs with a
higher degree of fiber orientation than non-treated
CAFs did (Fig. 5a). When we checked SNAI1 expression
and PDGFR-β phosphorylation, different levels of
response to the ligand were observed in CAFs. Inter-
estingly, basal levels of SNAI1 (without PDGF stimula-
tion) were associated with organization of ECM fibers
and the PDGFR-β phosphorylation levels correlated
directly with Snail1 expression levels. In addition, CAFs
with higher levels of Snail1 showed an anisotropic
organization of ECM fibers (Fig. 5b).
Snail1-expressing fibroblasts stimulate angiogenesis in the
colon tumor xenograft model
To study the Snail1-expressing effects of fibroblasts on
tumor angiogenesis in an in vivo tumor model, a xeno-
graft colon cancer model was generated. HT29-M6
human colon tumor cells were subcutaneously co-
injected with MEFs, either wild type or Snail1 KO. HT-
29 M6 were also injected alone.
A remarkable decrease in vascular irrigation was mac-
roscopically observed when we compared tumors gener-
ated by co-injection of tumor cells and Snail1 KO MEFs
vs. wt MEFs (Fig. 6a). Staining of vascular vessels with
PECAM-1 antibody supported the macroscopically
observed data (Fig. 6b, c).
Moreover, Masson staining was performed to analyze
Collagen I organization in the tumor mice models.
Although no differences were observed in the total Col-
lagen I, the organization of this protein depended on
Snail1 expression in MEFs. Thus, those tumors derived
from epithelial cells and Snail1 KO MEFs exhibited a
Fig. 5 PDGFR-β/Snail1-fibroblast expression as mediators of Matrix remodeling in cancer-associated fibroblasts. a PDGF-treated CAFs
showed greater fiber orientation in derived ECM. b PDGFR-β phosphorylation levels were associated with SNAI1 expression levels in primary CAFs
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Fig. 6 SNAI1 expression stimulates angiogenesis in xenograft tumor models and is associated with angiogenesis markers in human tumor
samples. a, b Macroscopic and microscopic decrease of vascular irrigation in tumors derived from colon cells and Snail1 ko MEFs. c PCAM-1 and
Masson staining measurement in xenograft tumors. d Illustration of Masson staining in Snail1 wt or ko MEFs+ tumor colon cell-derived xenograft
tumors. e Representative images of a patient with SNAI1 expression and high degree of vasculature. f Direct association between SNAI1 expression
and the degree of vasculature in human colon tumor samples
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lower organization than tumors derived formed by HT-
29M6 plus SNAI1 wt MEFs (Fig. 6c, d).
Tumors formed by HT29-M6 human colon tumor cells
without co-injection of fibroblasts, showed vascular vessel
and Collagen I organization between those observed in
tumor with co-injection of Snail1 KO or wt MEFs (Fig.
6c), suggesting that Snail1 KO MEFs prevents activation
of resident fibroblasts.
Thus, this analysis demonstrated that the Snail1 status
of co-injected fibroblasts determined angiogenesis beha-
vior and ECM Collagen I organization of endogenous
endothelial cells in xenograft colon cancer models.
Snail1 expression in fibroblasts is associated with
endothelial cell markers in human colon tumor samples
Finally, the expression of Snail1, CD34 and CD31 as
angiogenic marker, was analyzed by IHC in a series of 53
colon cancer patients. Snail11 expression in tumor stroma
was categorized as presence or absence of expression,
given the low number of expressing cells. However, the
expression of CD34 and CD31 was measured at three
levels, in which “Grade 1” corresponded to those samples
with lower staining and “Grade 3” to those with highest
expression.
As expected, CD34 and CD31 showed a statistical
association (Sup. Fig. 10A). The analysis showed a direct
association between SNAI1 presence and CD34 but not
with CD31. Thus, SNAI1-positive tumors showed a 1.27
rate of vasculature markers expression, compared with
negative SNAI1 samples. Moreover, the percentage of
patients with “Grade 3” of CD34, and thus more vascu-
lature, was higher among SNAI1-positive tumors; on the
contrary, those tumors without SNAI1 expression pre-
sented the greatest percentage of patients with low
angiogenesis or CD34 expression (patients with “Grade
1”) (Fig. 6e, f and Sup. Fig. 10B).
Discussion
In this study, we established for the first time a role for
ECM fiber alignment in tumor angiogenesis of colorectal
cancer patients via the PDGF/FAK/Snail1 pathway. Thus,
3D-ECMs derived from PDGF-stimulated fibroblasts
showed increased fiber deposition and alignment organi-
zation. Endothelial cell activation and tubulogenesis were
observed when these cell were seeded on 3D-ECMs.
Interestingly, when we inhibited the FAK/Snail1 expres-
sion in fibroblasts, the activation of endothelial cells was
blocked by a mechanism involving ECM fiber dis-
organization (Sup. Fig. 11). The in vivo significance of
these findings was supported by results obtained from
tumors generated by co-injection of fibroblasts and colon
cancer cells; those with Snail1-deficient cells were less
likely to induce neovessel formation. Finally, the clinical
relevance of these results was proved by the association
between Snail1 expression in the stromal compartment
and angiogenesis markers in tumor samples from color-
ectal cancer patients.
Cancer-Associated Fibroblasts (CAFs) are a hetero-
geneous population of activated fibroblasts present in the
tumor microenvironment that promote tumor growth
and progression1–3. PDGF ligands stimulate tumor
stroma recruitment of CAFs and are an important reg-
ulator of CAFs33. Thus, stromal PDGFR signaling exerts
prometastatic effects having a prognostic role in several
tumor types33. PDGF stimulates the synthesis of ECM
proteins, by fibroblasts, such as Hyaluronan34, Fibronectin
ED-A and Collagen I35. ECM dynamics involve changes in
the amount, composition or topography of the fibers,
which may result in disorganization and deregulation of
its essential properties and could lead to abnormal
behavior of cells in tumor tissues19,36. In line with these
data, we demonstrated that BJ-hTERT fibroblasts increase
matrix deposition and alignment upon PDGF treatment,
which results in an anisotropic organization of both
Collagen I and Fibronectin ECM fibers. Supporting these
data, and in line with previously described data in which
p65 subunit of NF-κB participate in the activation of
fibronectin transcription, an increase of p65 phosphor-
ilation was observed in BJ-hTERT fibroblasts under PDGF
stimulation. Moreover, data derived by gene expression
profile of nonstimulated and PDGF-stimulated BJhTERT
fibroblasts supports also these findings, since PDGF sti-
mulation of fibroblasts was involve in the regulation of
many genes related with ECM. These changes in ECM
properties were also validated when using NFs and CAFs
established from normal or tumor samples derived from
colorectal cancer patients. As expected from their acti-
vated phenotype, CAFs resemble PDGF-treated fibroblast
behavior, as they produced parallel fiber alignment and
dense matrices unlike NFs. Furthermore, PDGF-treated
CAFs showed greater organization of ECM fibers than
non-treated CAFs do.
During tumor growth, new blood vessel formation is
crucial to face the increasing demand for nutrient, oxygen
and waste exchange37. The organization and composition
of the ECM control endothelial cell activities, such as cell
survival and proliferation, vessel lumen formation and
tubulogenesis, and provide tracks to guide endothelial cell
migration and branching37. Similarly β1 integrin subunits
is involved with establishment and stiffness of collagen
fibers to form ECM scaffold. Moreover, endothelial cell
adhesion to collagen and fibronectin are mediated by β1
and β3 integrin subunits which play a pivotal role during
tumor angiogenesis and are highly expressed on activated
endothelial cells and new-born38,39. Despite the above-
mentioned findings, the cross-talk mediated by CAFs and
ECM fiber organization and its association with the
angiogenesis process has not yet been fully studied. In this
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study, we found that PDGF-activated fibroblasts induced
ECM deposition with anisotropic organization of fibers
and that these fibers’ alignment favored endothelial cell
attachment to ECM and activation, which results in
increased tubulogenesis. Accordingly, the tubulogenesis
process was not found in HUVECs on matrices from
PDGF-stimulated fibroblasts treated with LOX inhibitor.
Consistent with our data, it has been described that
Collagen I is a potent pro-vascular tube morphogenesis in
3D matrices, increasing tissue stiffness and remodeling
ECM to provide a network of tracks that support migra-
tion of cells27,37. Accordingly, our data showed that
PDGF-treated fibroblasts embedded in Collagen I gels
generated a stiff ECM, as demonstrated by its increased
contraction capacity. However, Western Blot found no
changes of PDGF-stimulated fibroblasts or LOX-treated
fibroblasts in LOX protein, suggesting that other proteins
may be regulating the process of fiber alignment in our
model.
Growth factors, such as PDGF, or phosphorylate
receptor tyrosine kinases (RTKs), result in activation of
three key downstream pathways commonly mutated in
tumors: the small GTPase Ras/ERK, the Phosphatidyli-
nositol 3′-Kinase/Akt and the Focal Adhesion Kinase
(FAK)40. In our study, the Akt inhibitor completely
reverted Collagen I deposition, while ERK and FAK
inhibitors revealed only a partial blockade. However,
when analyzing the organization of ECM fibers, FAK was
the main protein regulating ECM dynamics mediated by
PDGF, and FAK inhibition led to the disorganization of
fibroblasts and fibers. In addition, the tubulogenesis pro-
cess was completely inhibited on fibroblast 3D-ECMs
treated with the FAK inhibitor. Accordingly, survival of
endothelial cells during angiogenesis is mediated by
FAK41 and its deregulation is associated with several
carcinomas, including colon carcinoma42.
Snail1 is a transcriptional factor that initiates the EMT,
a common process observed in several tumors17. In
fibroblasts, PDGF promotes an activated phenotype and
induces Snail1 that acts as a main regulator of both gene
expression and functional properties in these cells23,24.
Since Snail1 expression in fibroblasts predicts outcome of
colon cancer patients, we recently proposed it as a marker
of activated fibroblasts, which lead to the production of
soluble pro-migratory molecules, resulting in cancer cell
invasion18,19,21,43,44. In addition, Snail1 plays an important
role in ECM composition by modifying Collagen and
Fibronectin deposition and alignment19,25,28–31. Inversely,
Collagen I receptor DDR2 prevents Snail1 degradation,
reinforcing ECM fiber organization and stiffness30,31. We
also previously described that expression of Snail1,
induced by TGFβ in fibroblasts, is required for the acti-
vation of RhoA and the acquisition of a myofibroblastic
phenotype. As a consequence, scattered Snail1-expressing
fibroblasts impose a mechanical microenvironment nee-
ded for breast cancer cell migration and invasiveness19.
However, no links between Snail1 activity and the mod-
ulation of angiogenesis through changes in ECM prop-
erties have been found. Currently, we showed that PDGF
treatment increases Snail1 expression levels and nuclear
translocation in fibroblasts and CAFs. Ectopic Snail
expression in human fibroblasts increase in a synergic
manner the PDGF regulation on the transcription of
several ECM proteins. Moreover, Snail1 depletion in
fibroblasts resulted in deregulation of fibroblasts and
ECM organization together with a decrease in p65 subunit
phosphorilation. Those CAFs in which ligand responses
were more clearly observed generated a more aligned
pattern of ECM fibers together with a higher increase in
Snail1 expression. In addition, HUVECs seeded on 3D-
ECMs derived from Snail1 KO fibroblasts did not form
capillary-like structures and displayed lower levels of
endothelial activation and attachment markers. In support
of our data, some evidence has shown an association
between Snail1 and angiogenesis in mouse models45,46,47.
In addition, although both PI3K/Akt and FAK inhibi-
tion decreased the expression of the cytoskeletal protein
α-SMA, only the FAK inhibitor decrease Snail1 protein.
Thus, blocking FAK in fibroblasts revealed a similar pat-
tern of ECM fibers and tubulogenesis in HUVECs as
Snail1-depletion fibroblasts and BAPN-treated ECMs.
These data suggest that the PDGF, FAK and Snail1 reg-
ulate cell morphology, leading to aligned ECM fibers that
serve as tracks for the tubulogenesis process. It has also
been demonstrated that Snail1 activates FN1 promoter
and also controls α-SMA and the formation of stress
fibers19,25. In a theoretical loop, the resulting aligned
Fibronectin fibers work as a template for the assembly of
other ECM molecules, such as Collagen, which are cross-
linked by LOX. In turn, the DDR2 Collagen receptor is
activated, leading to Snail1 stabilization19,30.
During the angiogenic process, the activated cell, called
the tip cell, invades the ECM. Adjacent cells, referred to as
stack cells, proliferate and follow the tip cell, resulting in
the formation of a sprout. This process has been asso-
ciated with collective endothelial cell migration47. In this
study, we have shown that PDGF-treated Snail1-expres-
sing fibroblasts generated organized 3D-ECMs, increasing
proliferation and collective invasion as a cohort of
HUVECs that indicated the activation of the sprout pro-
cess in endothelial cell. However, despite the present
study and previous ones, the molecular pathways and the
spatiotemporal regulation of angiogenic morphogenesis
remain largely unknown.
Xenografted tumors generated by co-injection of
Snail1-deficient fibroblasts and colon cancer cells were
less able to induce neovessel formation and to organize
the Collagen I fibers in the ECM. These data strongly
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supports the in vivo significance of the present study and
suggest that these Snail-expressing fibroblast effects might
be mediated by ECM remodeling and angiogenesis reg-
ulation. The data observed with HT29-M6 cells without
co-injection are also in accordance since in these tumor
the stroma was formed by resident fibroblasts of the mice.
Our data, showing that tumors formed with HT29-M6
and KO MEFs displayed lower angiogenesis than tumors
with only HT-29M6 (but less than with wt MEFs) suggest
that KO MEFs are protecting resident fibroblast from
activation. A similar results has been obtained in a model
of breast tumor where MEFs KO protected from epithelial
tumor metastasis48.
Finally, the analysis of human tumor samples showed an
association between Snail1 expression in the stromal
compartment and the angiogenesis marker CD34, but not
with CD31. CD34 is expressed in vascular endothelial
progenitors while CD31 is expressed in most of endothe-
lial cells49. This suggests that Snail1, as CD34, would be a
marker of neoangiogenesis, but not of regular vasculature,
as CD31. Although these analyses need to be extended
with larger patient series, the increase of angiogenesis in
those tumors with the highest degrees of Snail1 expression
supports evidence for the biological effects of Snail1-
expressing fibroblasts on endothelial cell activation.
Experimental studies have brought some controversy
about PDGFR-β function in endothelial cells. We did not
observe PDGFR-β expression in cultured HUVECs upon
PDGF treatment or under co-culture with fibroblasts. Our
results are in line with the analysis in knockout mice that
do not show evidences for PDGF signaling in endothelial
cells50. Thus the expression of Snail protein as a mediator
between PDGF and endothelial cell activation might be an
explanation for the confusion of PDGF functions in
endothelial cells.
Thought the inhibition of the PDGF ligand was suc-
cessful in therapeutic angiogenesis in diverse preclinical
models, the expected results failed to occur in clinical
trials26. According to our results this might be con-
sequence of the different fibroblast infiltration in tumors
and the expression of angiogenic mediators. Therefore,
the analysis of Snail1 expression in tumor stromal fibro-
blasts might be used as a potential biomarker to identify
sub-groups of patients who might respond better to
therapy and thus to improve personal treatments.
Materials and methods
Reagents
Primary antibodies used in this work were β-actin
(Abcam, ab8226), SNAI1 EC3 (ref20.), PY99 (Santa Cruz,
sc7020), PDGFR-β (Cell Signaling, 3169), ERK1/2 (Cell
Signaling, 9102), p-ERK1/2 (Cell Signaling, 9109), Akt
(Cell Signaling, 4691), p-Akt (Cell Signaling, 4060), FAK
(Cell Signaling, 3285), p-FAK (Cell Signaling, 3281), VE-
Cadherin (Abcam, ab33168), VCAM-1 (Abcam, ab98954),
MMP-9 (Abcam, ab38898), Snail (ref20.), MT1-MMP
(Abcam, ab51074), CD31/PCAM-1 (1:10, SC-506) Fibro-
nectin (DAKO, A0245), Beta 1 integrin (Cell Signaling,
34971 S), Beta 3 integrin (Cell signaling, 13166 S), NF-KB
p65 (Cell signaling, 8242 S), Phospho-NF-KBp65 (Cell
signaling 3033 S) and Collagen I (Abcam, ab34710). Sec-
ondary antibodies used were anti-Mouse or anti-Rabbit
IgG Antibody DyLight™ 680 or 800 Conjugate.
Other compounds used were PDGF-BB (Peprotech, 100-
14B), BAPN: 3-Aminopropionitrile fumarate salt (Sigma,
A3134), FAK inhibitor, PF-573228 (PZ0117, Sigma), ERK
inhibitor, U0126-monoethanolate (Sigma, U120) and PI3K/
Akt inhibitor LY294002 hydrochloride (Sigma, L9908).
Tube formation assay on 3-D matrices
For the angiogenesis assay on 3-D fibroblast-derived
matrices, HUVECs were maintained in EGM-2 containing
2% FCS. After 8 h of starving in EGM-2 without FCS, 2 ×
105 cells/well were seeded in FCS-depleted medium onto
6-well tissue culture plates coated with 3-D fibroblast-
derived matrices. Cells were cultured for 16 h and then
capillary-like tubes were analyzed.
Proliferation assay on 3-D matrices
HUVEC cells were seeded at a density of 15,000 cells/
well onto 96-well tissue culture plates coated with 3-D
fibroblast-derived matrices from Snail1 wt and KO MEFs.
After 72 h proliferation was analyzed. For details see
Supplementary Information.
Organotypic co-culture invasion assay on collagen gel
Collagen gels were prepared by mixing 5 volumes of type
I Collagen (3mg/ml Sigma), 2 volumes of DMEM 10%
FBS, 1 volume of Reconstitution Buffer (50mM NaOH,
260mM NaHCO3, 200mM HEPES) and 1 volume of FBS
with fibroblasts (resuspended at a density of 5 × 105 cells/
ml). 1.8ml of the gel mixture was placed in each transwell-
insert of a 6-well plate and allowed to polymerize at 37 °C
for 1 h. After the gel solidified, the bottom chamber was
filled with 2.5ml of 3D co-culture medium. Then,
HUVECs were resuspended in 3D-medium (1:1 of DMEM
10% FBS and EGM-2 2% FBS) at a concentration of 2 × 105
cells/ml, added to the gel and incubated at 37 °C. Every
2–3 days, medium from both well and insert was replaced
by 3D co-culture medium containing PDGF treatment
(10 ng/ml). After 6 days, the cultures were “lifted” to the
air–liquid interface by adding 1ml media to the bottom
chamber only, allowing the airway endothelial cells seeded
on the apical chamber to be exposed to air. The cells were
allowed to grow for an additional 5 days and were fixed in
formalin solution overnight at room temperature and
embedded in paraffin. Vertical sections (4 μm) with
hematoxylin and eosin (H&E) were stained.
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Other methods, including “Culture cell lines2, “Stromal
Fibroblast-Derived 3-D Matrix Production”, “Western
Blotting and Immunofluorescence details”, “Generation of
Snail1 modified cell lines and PCR array”, Proliferation
assay”, “In vivo xenograft tumor model”, “Immunohis-
tochemistry and Masson’s procedures” and “Statistical
analysis” are described in the Supplmentary Information.
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